Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
29.31
+0.87 (3.06%)
Feb 9, 2026, 1:17 PM EST - Market open
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $3.31 billion as of February 9, 2026. Its market cap has decreased by -14.91% in one year.
Market Cap
3.31B
Enterprise Value
2.44B
1-Year Change
-14.91%
Ranking
Category
Stock Price
$29.31
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $3.31B, an increase of 4,174.96%. That is a compound annual growth rate of 41.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 3.21B | -19.16% |
| Dec 31, 2025 | 3.98B | -11.32% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
| Apr 29, 2015 | 77.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Centessa Pharmaceuticals | 3.43B |
| Arcutis Biotherapeutics | 3.35B |
| Denali Therapeutics | 3.29B |
| Alumis | 3.26B |
| Xenon Pharmaceuticals | 3.20B |
| Legend Biotech | 3.16B |
| Vera Therapeutics | 3.09B |
| Edgewise Therapeutics | 3.08B |